Article: Immediate effects of tobramycin on human cochlea and correlation with serum tobramycin levels

Electrocochleography was performed on three patients to monitor the intravenous administration of tobramycin. When peak serum tobramycin levels exceeded 8-10 mug/ml an immediate dramatic reduction in cochlear output was observed, which recovered fully as serum levels fell. The patients had no auditory or vestibular symptoms either during or after treatment.

Citing Articles

Basis for an adequate dosage of aminoglycoside antibiotics.

Luthy R Infection. 1980; Suppl 1:58-61.

PMID: 7399715 DOI: 10.1007/BF01644937.

Therapeutic drug monitoring of aminoglycoside antibiotics.

Reeves D Infection. 1980; 8 Suppl 3:S 313-20.

PMID: 6997210 DOI: 10.1007/BF01639603.

The influence of ototoxic drugs on brainstem auditory evoked potentials in man.

Guerit J, Mahieu P, Herbay S Arch Otorhinolaryngol. 1981; 233(2):189-99.

PMID: 6797396 DOI: 10.1007/BF00453643.

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.

Gatell J, FERRAN F, Araujo V, Bonet M, Soriano E, Traserra J Antimicrob Agents Chemother. 1987; 31(9):1383-7.

PMID: 3674849 PMC: 174947. DOI: 10.1128/AAC.31.9.1383.

Shifts in auditory brainstem response latencies following plasma-level-controlled aminoglycoside therapy.

Hotz M, Allum J, Kaufmann G, Follath F, PFALTZ C Eur Arch Otorhinolaryngol. 1990; 247(4):202-5.

PMID: 2375861 DOI: 10.1007/BF00178984.

References

1.

Meyer R, Young L, Armstrong D . Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol. 1971; 22(6):1147-51. PMC: 376501. DOI: 10.1128/am.22.6.1147-1151.1971. View

2.

Postma D, Pecorak J, Prazma J, Logue S, Fischer N . Outer hair cell loss and alterations in glycogen due to tobramycin sulfate. Arch Otolaryngol. 1976; 102(3):154-9. DOI: 10.1001/archotol.1976.00780080076009. View

3.

Crawford L, Bowen J . Calcium binding as a property of kanamycin. Am J Vet Res. 1971; 32(2):357-9. View

4.

WERSAELL J, Flock A . SUPPRESSION AND RESTORATION OF THE MICROPHONIC OUTPUT FROM THE LATERAL LINE ORGAN AFTER LOCAL APPLICATION OF STREPTOMYCIN. Life Sci (1962). 1964; 3:1151-5. DOI: 10.1016/0024-3205(64)90132-8. View

5.

JAO R, JACKSON G . GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION. JAMA. 1964; 189:817-22. DOI: 10.1001/jama.1964.03070110019004. View

6.

KUBIKOWSKI P, SZRENIAWSKI Z . THE MECHANISM OF THE NEUROMUSCULAR BLOCKADE BY ANTIBIOTICS. Arch Int Pharmacodyn Ther. 1963; 146:549-60. View

7.

BRAZIL O, Corrado A . The curariform action of streptomycin. J Pharmacol Exp Ther. 1957; 120(4):452-9. View

8.

MIZUKOSHI O, DALY J . Oxygen consumption in normal and kanamycin damaged cochleae. Acta Otolaryngol. 1967; 64(1):45-54. DOI: 10.3109/00016486709139091. View

9.

Iinuma T, MIZUKOSHI O, DALY J . Possible effects of various ototoxic drugs upon the ATP-hydrolyzing system in the stria vascularis and spiral ligament of the guinea pig. Laryngoscope. 1967; 77(2):159-70. DOI: 10.1288/00005537-196702000-00002. View

10.

Aran J, DARROUZET J . Observation of click-evoked compound VIII nerve responses before, during, and over seven months after kanamycin treatment in the guinea pig. Acta Otolaryngol. 1975; 79(1-2):24-32. DOI: 10.3109/00016487509124650. View

11.

Traub W, RAYMOND E . Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate. Appl Microbiol. 1972; 23(1):4-7. PMC: 380267. DOI: 10.1128/am.23.1.4-7.1972. View

Immediate Effects of Tobramycin on Human Cochlea and Correlation with Serum Tobramycin Levels